-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-11-13
NUVL:NSD-Nuvalent Inc (USD)
COMMON STOCK | Other |
Last Closing
USD 90.34Change
-0.65 (-0.71)%Market Cap
USD 9.24MVolume
0.49MAnalyst Target
N/AVerdict
Verdict
Values as of: 2024-11-13
COMMON STOCK | Other |
Last Closing
USD 90.34Change
-0.65 (-0.71)%Market Cap
USD 9.24MVolume
0.49MAnalyst Target
N/AVerdict
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
WOOF | Pet Acquisition LLC |
-0.16 (-3.66%) |
USD 7.56B |
JSM | Navient Corporation SR NT 6% 1.. |
+0.06 (+0.30%) |
USD 5.42B |
BHFAL | Brighthouse Financial Inc |
-0.15 (-0.60%) |
USD 5.13B |
RGC | Regencell Bioscience Holdings .. |
-0.03 (-0.47%) |
USD 3.60B |
OB | Outbrain Inc |
+0.18 (+3.52%) |
USD 1.71B |
RILYG | B. Riley Financial Inc. 5.00% .. |
-0.20 (-1.70%) |
USD 0.54B |
RILYZ | B. Riley Financial Inc. 5.25% .. |
-0.22 (-2.12%) |
USD 0.54B |
NEWTZ | Newtek Business Services Corp... |
N/A |
USD 0.45B |
NEWTI | NewtekOne, Inc. 8.00% Fixed Ra.. |
N/A |
USD 0.43B |
GAINN | Gladstone Investment Corporati.. |
-0.09 (-0.37%) |
USD 0.39B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
DWAS | Invesco DWA SmallCap Mome.. | 1.12 % | 0.60 % |
-0.99 (0%) |
USD 0.97B |
CHNA | 0.00 % | 0.62 % |
N/A |
N/A | |
CHNA | 0.00 % | 0.79 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Other) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 22.76% | 91% | A- | 76% | C+ | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 22.76% | 91% | A- | 75% | C | ||
Trailing 12 Months | |||||||
Capital Gain | 53.12% | 93% | A | 83% | B | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 53.12% | 93% | A | 82% | B | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 80.24% | 93% | A | 91% | A- | ||
Dividend Return | 80.24% | 93% | A | 91% | A- | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 92.64% | 17% | F | 23% | F | ||
Risk Adjusted Return | 86.62% | 100% | F | 93% | A | ||
Market Capitalization | 9.24M | 24% | F | 12% | F |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
The company has negative book value.